相关实验视频
Updated: Feb 5, 2026

10:16
Generating Genetically Modified Plasmodium berghei Sporozoites
Published on: May 5, 2023
1.8K
在Plasmodium berghei中识别富含氨酸/氨酸的剪接因子1相互作用蛋白
Mamoru Niikura1,2, Yuichi Koyama3, Yasuhiro Fukuda4
1Department of Medical Technology, School of Life and Environmental Science, Azabu University, Kanagawa, 252-5201, Japan. m-niikura@azabu-u.ac.jp.
Malaria journal
|February 3, 2026
概括
富含氨酸/氨酸的拼接因子1 (SR1) 与疟疾寄生虫中的核和蛋白相互作用. 这项研究确定了对寄生虫发育和功能至关重要的关键蛋白质相互作用.
科学领域:
- 疟疾学 疟疾学
- 分子寄生虫学 分子寄生虫学
- 蛋白质与蛋白质的相互作用
背景情况:
- 富含氨酸/氨酸的剪接因子1 (SR1) 对于原虫寄生虫的无性发展至关重要.
- 在疟疾寄生虫中,SR1的相互作用伙伴以前是未知的.
研究的目的:
- 为了识别与Plasmodium berghei.i.中的SR1相互作用的蛋白质.
- 研究SR1和RhopH2相互作用的发育阶段和细胞局部.
主要方法:
- 生成的转基因Plasmodium berghei表达绿色光蛋白融合的PbSR1 (PbSR1::GFP).
- 执行免疫沉与质谱学 (IP-MS) 结合,以识别相互作用的蛋白质.
- 利用活细胞光成像和西部斑分析来确定不同寄生虫阶段的蛋白质同局部和表达.
主要成果:
- PbSR1::GFP主要局限于核,有一些细胞质存在.
- IP-MS确定了PbSR1与核蛋白 (RNA结合蛋白,小核核核蛋白) 和细胞质蛋白 (RhopH1,RhopH2,RhopH3) 之间的相互作用.
- 观察到PbSR1和RhopH2的同定位在热细胞和体细胞的细胞质中,但不是在成熟的分裂细胞或 merozoites.
结论:
- 在疟疾寄生虫中,PbSR1与核蛋白和虫蛋白相互作用.
- 热细胞,不成熟的分裂细胞和体细胞是细胞质PbSR1-RhopH2相互作用的候选阶段.
相关概念视频
RNA Splicing
60.6K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.6K
Alternative RNA Splicing
25.2K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.2K
Alternative RNA Splicing
5.2K
5.2K
Factors Affecting Protein-Drug Binding: Drug Interactions
605
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
605
Factors Affecting Protein-Drug Binding: Protein-Related Factors
565
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
565
Factors Affecting Protein-Drug Binding: Drug-Related Factors
486
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
486

